GVK Biosciences is acquiring Aragen Bioscience for an undisclosed amount.
Aragen, headquartered in Morgan Hill, Calif., is a contract research organization that provides discovery, characterization, assessment and development of biologic and diagnostic medical products.
Hyderabad, India-based GVK provides research and development for pharmaceutical products. The company expects the acquisition to enhance its research and development offerings. This is GVK’s first international acquisition.
Other recent pharmaceutical deals includePar Pharmaceutical Companies Inc.’s deal for JHP Group Holdings and Forest Laboratories Inc.’s purchase of Aptalis Pharma.